Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zentalis Pharmaceuticals (ZNTL) Net Margin (2024)

Historic Net Margin for Zentalis Pharmaceuticals (ZNTL) over the last 1 years, with Q4 2024 value amounting to 176.71%.

  • Zentalis Pharmaceuticals' Net Margin changed N/A to 176.71% in Q4 2024 from the same period last year, while for Sep 2025 it was 555.8%, marking a year-over-year decrease of 1133900.0%. This contributed to the annual value of 246.0% for FY2024, which is N/A changed from last year.
  • As of Q4 2024, Zentalis Pharmaceuticals' Net Margin stood at 176.71%.
  • Zentalis Pharmaceuticals' 5-year Net Margin high stood at 24.75% for Q1 2024, and its period low was 176.71% during Q4 2024.